685 is the total number of securities Eventide Asset Management has owned. The longest Eventide Asset Management has owned a single stock is 43 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
LOW | LOWES COS INC | 43 | 43 | 1.03% | 2.05% | 3.22% | Q4 2013 | Q2 2024 | 43 |
PANW | PALO ALTO NETWORKS INC | 43 | 43 | 0.48% | 1.75% | 3.63% | Q4 2013 | Q2 2024 | 43 |
ASML | ASML HOLDINGS NV | 43 | 43 | 0.56% | 1.33% | 1.90% | Q4 2013 | Q2 2024 | 43 |
RGEN | REPLIGEN CORP | 43 | 43 | 0.11% | 0.29% | 0.45% | Q4 2013 | Q2 2024 | 43 |
VCYT | VERACYTE INC | 41 | 41 | 0.18% | 0.65% | 1.46% | Q2 2014 | Q2 2024 | 41 |
NBIX | NEUROCRINE BIOSCIENCES... | 40 | 40 | 0.11% | 0.48% | 1.07% | Q4 2013 | Q3 2023 | 40 |
LRCX | LAM RESEARCH CORP | 38 | 38 | 0.82% | 1.78% | 3.44% | Q1 2015 | Q2 2024 | 38 |
COLL | COLLEGIUM PHARMACEUTIC... | 37 | 37 | 0.63% | 1.31% | 2.64% | Q2 2015 | Q2 2024 | 37 |
BPMC | BLUEPRINT MEDICINES CORP | 36 | 36 | 0.13% | 0.63% | 1.32% | Q3 2015 | Q2 2024 | 36 |
XPO | XPO LOGISTICS INC | 34 | 34 | 0.00% | 1.58% | 3.76% | Q4 2014 | Q1 2023 | 34 |
MGA | MAGNA INTL INC | 33 | 33 | 0.71% | 1.50% | 2.49% | Q4 2013 | Q4 2021 | 33 |
NEP | NEXTERA ENERGY PARTNER... | 33 | 33 | 0.00% | 1.46% | 2.17% | Q3 2015 | Q3 2023 | 33 |
CCI | CROWN CASTLE INTL CORP... | 33 | 33 | 0.58% | 1.44% | 3.26% | Q1 2015 | Q1 2023 | 33 |
BEP | BROOKFIELD RENEWABLE P... | 33 | 33 | 0.00% | 0.43% | 1.26% | Q3 2015 | Q3 2023 | 33 |
TSM | TAIWAN SEMICONDUCTOR M... | 17 | 16 | 0.00% | 0.18% | 0.79% | Q3 2015 | Q2 2024 | 33 |
HASI | HANNON ARMSTRONG SUST ... | 32 | 32 | 0.08% | 0.65% | 1.00% | Q4 2015 | Q3 2023 | 32 |
WCN | WASTE CONNECTIONS INC | 31 | 31 | 0.90% | 1.77% | 2.44% | Q4 2016 | Q2 2024 | 31 |
SRPT | SAREPTA THERAPEUTICS INC | 15 | 6 | 0.14% | 1.53% | 5.19% | Q4 2013 | Q2 2024 | 31 |
ASND | ASCENDIS PHARMA A/S | 29 | 29 | 0.30% | 3.30% | 6.88% | Q4 2016 | Q4 2023 | 29 |
TTD | THE TRADE DESK INC | 29 | 29 | 0.84% | 2.15% | 3.34% | Q2 2017 | Q2 2024 | 29 |
EXAS | EXACT SCIENCES CORP | 29 | 29 | 0.22% | 1.60% | 3.54% | Q2 2017 | Q2 2024 | 29 |
HUBS | HUBSPOT INC | 29 | 29 | 0.85% | 1.49% | 2.12% | Q2 2017 | Q2 2024 | 29 |
XNCR | XENCOR INC | 29 | 29 | 0.21% | 0.33% | 0.59% | Q1 2015 | Q1 2022 | 29 |
FIVN | FIVE9 INC | 28 | 28 | 0.44% | 1.83% | 3.13% | Q3 2017 | Q2 2024 | 28 |
IPHI | INPHI CORP | 28 | 28 | 0.75% | 1.22% | 2.32% | Q4 2013 | Q3 2020 | 28 |
APTV | APTIV PLC | 27 | 27 | 0.30% | 0.98% | 1.48% | Q4 2017 | Q2 2024 | 27 |
GWPH | GW PHARMACEUTICALS PLC | 27 | 27 | 0.18% | 0.51% | 1.28% | Q2 2014 | Q4 2020 | 27 |
ROP | ROPER TECHNOLOGIES INC | 26 | 26 | 0.78% | 1.95% | 2.52% | Q1 2018 | Q2 2024 | 26 |
ARGX | ARGENX SE | 26 | 26 | 0.34% | 1.42% | 2.84% | Q1 2018 | Q2 2024 | 26 |
STML | STEMLINE THERAPEUTICS INC | 26 | 26 | 0.22% | 0.77% | 1.49% | Q4 2013 | Q1 2020 | 26 |
MTD | METTLER TOLEDO INTERNA... | 25 | 25 | 0.65% | 1.97% | 3.70% | Q2 2018 | Q2 2024 | 25 |
LEA | LEAR CORP | 25 | 25 | 0.71% | 1.87% | 3.25% | Q4 2013 | Q4 2019 | 25 |
XLRN | ACCELERON PHARMA INC | 20 | 5 | 0.13% | 0.58% | 1.45% | Q2 2014 | Q1 2021 | 25 |
RARE | ULTRAGENYX PHARMACEUTI... | 18 | 7 | 0.21% | 0.32% | 0.59% | Q2 2014 | Q1 2024 | 25 |
SPLK | SPLUNK INC | 24 | 24 | 0.67% | 1.75% | 2.62% | Q4 2014 | Q3 2020 | 24 |
KAR | KAR AUCTION SVCS INC | 24 | 24 | 0.46% | 1.62% | 2.60% | Q4 2013 | Q3 2019 | 24 |
STKL | SUNOPTA INC | 24 | 24 | 0.25% | 1.26% | 2.47% | Q4 2013 | Q3 2019 | 24 |
BMRN | BIOMARIN PHARMACEUTICA... | 20 | 4 | 0.22% | 0.35% | 0.49% | Q4 2013 | Q3 2023 | 24 |
MIC | MACQUARIE INFRASTRUCTU... | 23 | 23 | 0.36% | 2.43% | 3.85% | Q4 2013 | Q2 2019 | 23 |
BLUE | BLUEBIRD BIO INC | 23 | 23 | 0.14% | 2.02% | 3.90% | Q4 2013 | Q2 2019 | 23 |
SAGE | SAGE THERAPEUTICS INC | 23 | 23 | 0.15% | 1.36% | 4.41% | Q3 2014 | Q1 2020 | 23 |
WBC | WABCO HLDGS INC | 22 | 22 | 0.61% | 1.71% | 2.36% | Q4 2013 | Q1 2019 | 22 |
MGNX | MACROGENICS INC | 20 | 2 | 0.12% | 0.56% | 1.32% | Q4 2013 | Q2 2019 | 22 |
KALV | KALVISTA PHARMACEUTICA... | 20 | 2 | 0.02% | 0.41% | 1.01% | Q1 2017 | Q4 2022 | 22 |
PLD | PROLOGIS INC. | 22 | 22 | 0.02% | 0.17% | 0.50% | Q2 2018 | Q3 2023 | 22 |
W | WAYFAIR INC | 21 | 21 | 0.80% | 1.93% | 3.28% | Q4 2016 | Q4 2021 | 21 |
ODFL | OLD DOMINION FREIGHT L... | 20 | 1 | 0.06% | 1.82% | 3.26% | Q3 2016 | Q2 2024 | 21 |
IDXX | IDEXX LABS INC | 21 | 21 | 0.76% | 1.74% | 2.42% | Q2 2019 | Q2 2024 | 21 |
BHVN | BIOHAVEN PHARMACTL HLD... | 21 | 21 | 0.08% | 1.68% | 3.52% | Q2 2017 | Q2 2022 | 21 |
ISRG | INTUITIVE SURGICAL INC | 21 | 21 | 0.27% | 0.38% | 0.57% | Q2 2019 | Q2 2024 | 21 |
ABBV | ABBVIE INC | 20 | 20 | 0.01% | 2.39% | 3.42% | Q4 2013 | Q3 2018 | 20 |
POOL | POOL CORPORATION | 20 | 20 | 1.11% | 1.56% | 1.86% | Q3 2019 | Q2 2024 | 20 |
AGIO | AGIOS PHARMACEUTICALS INC | 20 | 20 | 0.21% | 1.34% | 3.70% | Q4 2013 | Q3 2018 | 20 |
PFPT | PROOFPOINT INC | 20 | 20 | 0.51% | 1.14% | 1.90% | Q1 2015 | Q4 2019 | 20 |
DDOG | DATADOG INC | 20 | 20 | 0.32% | 0.93% | 2.27% | Q3 2019 | Q2 2024 | 20 |
EXR | EXTRA SPACE STORAGE INC | 20 | 20 | 0.26% | 0.73% | 2.42% | Q1 2015 | Q4 2019 | 20 |
ACAD | ACADIA PHARMACEUTICALS... | 19 | 1 | 0.07% | 0.72% | 1.47% | Q4 2013 | Q4 2023 | 20 |
GLPG | GALAPAGOS NV | 20 | 20 | 0.12% | 0.29% | 0.87% | Q1 2016 | Q4 2020 | 20 |
IEX | IDEX CORP | 20 | 20 | 0.02% | 0.16% | 0.31% | Q3 2019 | Q2 2024 | 20 |
KRTX | KARUNA THERAPEUTICS INC | 19 | 19 | 0.16% | 1.34% | 2.30% | Q2 2019 | Q4 2023 | 19 |
DHI | D R HORTON INC | 19 | 19 | 0.03% | 1.23% | 2.03% | Q4 2019 | Q2 2024 | 19 |
TREX | TREX CO INC | 19 | 19 | 0.74% | 1.04% | 1.71% | Q4 2019 | Q2 2024 | 19 |
NOVT | NOVANTA INC | 19 | 19 | 0.29% | 0.50% | 0.73% | Q4 2019 | Q2 2024 | 19 |
SUPN | SUPERNUS PHARMACEUTICA... | 19 | 19 | 0.23% | 0.40% | 0.77% | Q1 2014 | Q3 2018 | 19 |
KLAC | KLA CORPORATION | 19 | 19 | 0.03% | 0.34% | 0.86% | Q4 2019 | Q2 2024 | 19 |
CERN | CERNER CORP | 19 | 19 | 0.24% | 0.34% | 0.45% | Q1 2014 | Q3 2018 | 19 |
ARE | ALEXANDRIA REAL ESTATE... | 19 | 19 | 0.04% | 0.08% | 0.12% | Q2 2018 | Q4 2022 | 19 |
CELG | CELGENE CORP | 18 | 18 | 0.39% | 2.59% | 4.26% | Q2 2014 | Q3 2018 | 18 |
TT | TRANE TECHNOLOGIES PLC | 18 | 18 | 0.05% | 2.13% | 4.54% | Q1 2020 | Q2 2024 | 18 |
CRWD | CROWDSTRIKE HLDGS INC | 18 | 18 | 1.23% | 2.00% | 3.26% | Q1 2020 | Q2 2024 | 18 |
STLD | STEEL DYNAMICS INC | 18 | 18 | 0.69% | 1.61% | 2.24% | Q1 2015 | Q2 2019 | 18 |
TSLA | TESLA MTRS INC | 18 | 18 | 0.37% | 0.88% | 1.60% | Q4 2013 | Q1 2018 | 18 |
AY | ATLANTICA YIELD PLC | 18 | 18 | 0.41% | 0.80% | 1.28% | Q2 2016 | Q3 2020 | 18 |
VRSK | VERISK ANALYTICS INC | 18 | 18 | 0.16% | 0.61% | 1.34% | Q1 2020 | Q2 2024 | 18 |
ATHN | ATHENAHEALTH INC | 18 | 18 | 0.10% | 0.59% | 1.70% | Q4 2013 | Q1 2018 | 18 |
MRTX | MIRATI THERAPEUTICS INC | 18 | 18 | 0.16% | 0.52% | 1.09% | Q2 2019 | Q3 2023 | 18 |
GBT | GLOBAL BLOOD THERAPEUT... | 9 | 9 | 0.04% | 0.49% | 1.20% | Q3 2015 | Q3 2020 | 18 |
QURE | UNIQURE NV | 10 | 8 | 0.04% | 0.49% | 1.18% | Q2 2014 | Q2 2020 | 18 |
MDB | MONGODB INC | 13 | 1 | 0.00% | 0.43% | 1.13% | Q3 2019 | Q2 2024 | 18 |
RCKT | ROCKET PHARMACEUTICALS... | 11 | 7 | 0.18% | 0.43% | 0.91% | Q1 2018 | Q2 2024 | 18 |
PRTA | PROTHENA CORP PLC | 11 | 1 | 0.06% | 0.35% | 0.52% | Q1 2014 | Q4 2023 | 18 |
ALNY | ALNYLAM PHARMACEUTICAL... | 15 | 3 | 0.20% | 0.34% | 0.60% | Q1 2015 | Q2 2024 | 18 |
XENE | XENON PHARMACEUTICALS INC | 12 | 6 | 0.12% | 0.33% | 0.50% | Q3 2018 | Q3 2023 | 18 |
EPIX | ESSA PHARMA INC | 18 | 18 | 0.04% | 0.31% | 1.04% | Q2 2018 | Q3 2022 | 18 |
SHW | SHERWIN WILLIAMS CO | 18 | 18 | 0.03% | 0.20% | 0.52% | Q1 2020 | Q2 2024 | 18 |
TWLO | TWILIO INC | 12 | 5 | 0.58% | 1.84% | 3.68% | Q1 2017 | Q3 2021 | 17 |
FPRX | FIVE PRIME THERAPEUTIC... | 17 | 17 | 0.08% | 1.70% | 3.25% | Q1 2014 | Q1 2018 | 17 |
SGEN | SEATTLE GENETICS INC | 14 | 3 | 0.34% | 1.28% | 2.76% | Q2 2015 | Q3 2020 | 17 |
ZNTL | ZENTALIS PHARMACEUTICA... | 17 | 17 | 0.30% | 1.19% | 3.28% | Q2 2020 | Q2 2024 | 17 |
CLDX | CELLDEX THERAPEUTICS I... | 17 | 17 | 0.13% | 0.98% | 2.35% | Q2 2020 | Q2 2024 | 17 |
ENTG | ENTEGRIS INC | 17 | 17 | 0.02% | 0.92% | 1.70% | Q2 2020 | Q2 2024 | 17 |
PEGI | PATTERN ENERGY GROUP INC | 17 | 17 | 0.00% | 0.91% | 1.32% | Q3 2015 | Q3 2019 | 17 |
STRO | SUTRO BIOPHARMA INC | 17 | 17 | 0.16% | 0.47% | 0.80% | Q3 2018 | Q3 2022 | 17 |
CRNX | CRINETICS PHARMACEUTIC... | 11 | 6 | 0.06% | 0.39% | 0.78% | Q3 2018 | Q2 2024 | 17 |
STE | STERIS PLC | 17 | 17 | 0.06% | 0.33% | 0.51% | Q2 2020 | Q2 2024 | 17 |
INSM | INSMED INC | 10 | 7 | 0.12% | 0.25% | 0.77% | Q4 2013 | Q2 2024 | 17 |
NTUS | NATUS MEDICAL INC DEL | 17 | 17 | 0.15% | 0.22% | 0.36% | Q4 2013 | Q4 2017 | 17 |
ABB | ABB LTD | 17 | 17 | 0.00% | 0.06% | 0.11% | Q3 2015 | Q3 2019 | 17 |
ETN | EATON CORP PLC | 17 | 17 | 0.00% | 0.04% | 0.08% | Q3 2015 | Q3 2019 | 17 |
ERIC | ERICSSON | 17 | 17 | 0.01% | 0.03% | 0.08% | Q3 2015 | Q3 2019 | 17 |
LOXO | LOXO ONCOLOGY INC | 16 | 16 | 0.11% | 1.21% | 2.65% | Q1 2015 | Q4 2018 | 16 |
LII | LENNOX INTL INC | 16 | 16 | 0.37% | 0.98% | 1.61% | Q4 2017 | Q3 2021 | 16 |
VRTX | VERTEX PHARMACEUTICALS... | 14 | 2 | 0.15% | 0.79% | 2.22% | Q4 2015 | Q2 2020 | 16 |
MPWR | MONOLITHIC PWR SYS INC | 16 | 16 | 0.39% | 0.76% | 1.39% | Q3 2020 | Q2 2024 | 16 |
LSCC | LATTICE SEMICONDUCTOR ... | 16 | 16 | 0.01% | 0.46% | 0.90% | Q3 2020 | Q2 2024 | 16 |
TTPH | TETRAPHASE PHARMACEUTI... | 9 | 7 | 0.07% | 0.42% | 1.26% | Q4 2013 | Q4 2017 | 16 |
SNPS | SYNOPSYS INC | 16 | 16 | 0.04% | 0.36% | 0.65% | Q3 2020 | Q2 2024 | 16 |
ATRC | ATRICURE INC | 16 | 16 | 0.16% | 0.26% | 0.42% | Q4 2013 | Q3 2017 | 16 |
SYY | SYSCO CORP | 16 | 16 | 0.04% | 0.16% | 0.29% | Q3 2020 | Q2 2024 | 16 |
LPT | LIBERTY PPTY TR | 16 | 16 | 0.00% | 0.02% | 0.03% | Q3 2015 | Q2 2019 | 16 |
CTAS | CINTAS CORP | 9 | 6 | 0.37% | 1.22% | 2.26% | Q4 2018 | Q3 2022 | 15 |
SPT | SPROUT SOCIAL INC | 15 | 15 | 0.59% | 1.01% | 1.60% | Q3 2020 | Q1 2024 | 15 |
VMC | VULCAN MATLS CO | 15 | 15 | 0.45% | 0.90% | 1.59% | Q1 2017 | Q3 2020 | 15 |
CGNX | COGNEX CORP | 9 | 6 | 0.33% | 0.48% | 0.81% | Q2 2014 | Q2 2022 | 15 |
CWEN | CLEARWAY ENERGY INC | 12 | 3 | 0.00% | 0.47% | 0.88% | Q3 2018 | Q2 2023 | 15 |
TSRO | TESARO INC | 15 | 15 | 0.05% | 0.32% | 0.57% | Q4 2014 | Q2 2018 | 15 |
PNR | PENTAIR PLC | 15 | 15 | 0.08% | 0.30% | 0.42% | Q4 2020 | Q2 2024 | 15 |
ETTX | ENTASIS THERAPEUTICS H... | 15 | 15 | 0.02% | 0.09% | 0.30% | Q3 2018 | Q1 2022 | 15 |
BDN | BRANDYWINE RLTY TR | 15 | 15 | 0.01% | 0.06% | 0.08% | Q3 2015 | Q1 2019 | 15 |
LXP | LEXINGTON REALTY TRUST | 15 | 15 | 0.00% | 0.02% | 0.03% | Q3 2015 | Q1 2019 | 15 |
AIMT | AIMMUNE THERAPEUTICS INC | 14 | 14 | 0.45% | 1.76% | 2.91% | Q1 2017 | Q2 2020 | 14 |
IDTI | INTEGRATED DEVICE TECH... | 14 | 14 | 1.09% | 1.31% | 1.64% | Q1 2015 | Q2 2018 | 14 |
BWA | BORGWARNER INC | 13 | 1 | 0.03% | 1.07% | 1.94% | Q4 2013 | Q4 2019 | 14 |
AYR | AIRCASTLE LTD | 14 | 14 | 0.45% | 0.78% | 1.90% | Q4 2013 | Q1 2017 | 14 |
ROL | ROLLINS INC | 7 | 3 | 0.33% | 0.73% | 1.45% | Q3 2016 | Q2 2024 | 14 |
DBVT | DBV TECHNOLOGIES S A | 14 | 14 | 0.14% | 0.38% | 0.57% | Q1 2015 | Q2 2018 | 14 |
MASS | 908 DEVICES INC | 14 | 14 | 0.17% | 0.33% | 0.66% | Q4 2020 | Q1 2024 | 14 |
TGTX | TG THERAPEUTICS INC | 11 | 3 | 0.12% | 0.22% | 0.32% | Q2 2014 | Q2 2024 | 14 |
FRC | FIRST REP BK SAN FRANC... | 14 | 14 | 0.03% | 0.20% | 0.39% | Q3 2019 | Q4 2022 | 14 |
FENC | FENNEC PHARMACEUTICALS... | 14 | 14 | 0.09% | 0.19% | 0.42% | Q4 2017 | Q1 2021 | 14 |
DRNA | DICERNA PHARMACEUTICAL... | 14 | 14 | 0.07% | 0.14% | 0.26% | Q2 2014 | Q3 2017 | 14 |
JCI | JOHNSON CTLS INTL PLC | 14 | 14 | 0.02% | 0.08% | 0.11% | Q3 2016 | Q4 2019 | 14 |
BG | BUNGE LIMITED | 14 | 14 | 0.01% | 0.05% | 0.08% | Q1 2016 | Q2 2019 | 14 |
WELL | WELLTOWER INC | 13 | 1 | 0.01% | 0.02% | 0.05% | Q4 2015 | Q3 2019 | 14 |
WAB | WABTEC CORP | 13 | 13 | 0.86% | 1.59% | 1.93% | Q4 2013 | Q4 2016 | 13 |
XMTR | XOMETRY INC | 13 | 13 | 0.02% | 1.17% | 3.34% | Q2 2021 | Q2 2024 | 13 |
CRUS | CIRRUS LOGIC INC | 13 | 13 | 0.52% | 1.06% | 1.84% | Q4 2015 | Q4 2018 | 13 |
MYOV | MYOVANT SCIENCES LTD | 13 | 13 | 0.20% | 1.02% | 2.06% | Q1 2017 | Q1 2020 | 13 |
NVAX | NOVAVAX INC | 13 | 13 | 0.12% | 0.99% | 2.03% | Q4 2013 | Q4 2016 | 13 |
MYOK | MYOKARDIA INC | 13 | 13 | 0.18% | 0.83% | 1.66% | Q3 2017 | Q3 2020 | 13 |
NVT | NVENT ELECTRIC PLC | 13 | 13 | 0.24% | 0.61% | 0.94% | Q2 2021 | Q2 2024 | 13 |
BEPC | BROOKFIELD RENEWABLE CORP | 13 | 13 | 0.33% | 0.47% | 0.68% | Q3 2020 | Q3 2023 | 13 |
A | AGILENT TECHNOLOGIES INC | 13 | 13 | 0.05% | 0.41% | 0.91% | Q3 2019 | Q3 2022 | 13 |
BOLD | AUDENTES THERAPEUTICS INC | 13 | 13 | 0.24% | 0.38% | 0.67% | Q3 2016 | Q3 2019 | 13 |
VYGR | VOYAGER THERAPEUTICS INC | 13 | 13 | 0.15% | 0.36% | 0.66% | Q4 2015 | Q4 2018 | 13 |
ELS | EQUITY LIFESTYLE PPTYS... | 11 | 2 | 0.01% | 0.18% | 0.30% | Q1 2020 | Q3 2023 | 13 |
OMED | ONCOMED PHARMACEUTICAL... | 13 | 13 | 0.10% | 0.16% | 0.28% | Q4 2013 | Q4 2016 | 13 |
SEP | SPECTRA ENERGY PARTNER... | 13 | 13 | 0.01% | 0.08% | 0.14% | Q3 2015 | Q3 2018 | 13 |
ZTS | ZOETIS INC | 8 | 2 | 0.01% | 0.05% | 0.09% | Q4 2019 | Q4 2023 | 13 |
APU | AMERIGAS PARTNERS L P | 9 | 4 | 0.01% | 0.04% | 0.06% | Q1 2016 | Q2 2019 | 13 |
VTR | VENTAS INC | 10 | 1 | 0.01% | 0.03% | 0.06% | Q1 2016 | Q3 2019 | 13 |
GH | GUARDANT HEALTH INC | 12 | 12 | 0.29% | 1.42% | 2.42% | Q3 2021 | Q2 2024 | 12 |
CPN | CALPINE CORP | 12 | 12 | 0.39% | 1.34% | 1.81% | Q4 2013 | Q3 2016 | 12 |
GLBE | GLOBAL E ONLINE LTD | 12 | 12 | 0.45% | 1.30% | 1.75% | Q3 2021 | Q2 2024 | 12 |
INST | INSTRUCTURE INC | 12 | 12 | 0.42% | 1.17% | 1.86% | Q4 2016 | Q3 2019 | 12 |
IMVT | IMMUNOVANT INC | 12 | 12 | 0.33% | 0.58% | 1.29% | Q2 2020 | Q1 2023 | 12 |
ONCE | SPARK THERAPEUTICS INC | 12 | 12 | 0.12% | 0.56% | 1.64% | Q2 2015 | Q1 2018 | 12 |
WVE | WAVE LIFE SCIENCES LTD | 12 | 12 | 0.23% | 0.55% | 0.79% | Q2 2016 | Q1 2019 | 12 |
WMB | WILLIAMS COS INC DEL | 11 | 1 | 0.05% | 0.40% | 0.64% | Q3 2019 | Q2 2024 | 12 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 7 | 5 | 0.16% | 0.35% | 0.66% | Q1 2015 | Q2 2024 | 12 |
ADCT | ADC THERAPEUTICS SA | 12 | 12 | 0.06% | 0.33% | 0.53% | Q2 2020 | Q1 2023 | 12 |
AGTC | APPLIED GENETIC TECHNO... | 12 | 12 | 0.08% | 0.29% | 0.65% | Q2 2014 | Q1 2017 | 12 |
ESI | ELEMENT SOLUTIONS INC | 12 | 12 | 0.13% | 0.29% | 0.37% | Q3 2021 | Q2 2024 | 12 |
CEMP | CEMPRA INC | 12 | 12 | 0.18% | 0.27% | 0.40% | Q4 2013 | Q3 2016 | 12 |
NDAQ | NASDAQ INC | 11 | 1 | 0.02% | 0.25% | 0.57% | Q2 2020 | Q2 2023 | 12 |
BRKR | BRUKER CORP | 7 | 5 | 0.14% | 0.24% | 0.32% | Q4 2013 | Q2 2024 | 12 |
INCY | INCYTE CORP | 11 | 1 | 0.12% | 0.23% | 0.35% | Q1 2016 | Q4 2023 | 12 |
GXO LOGISTICS INCORPOR... | 12 | 12 | 0.15% | 0.21% | 0.26% | Q3 2021 | Q2 2024 | 12 | |
CMS | CMS ENERGY CORP | 9 | 3 | 0.07% | 0.21% | 0.41% | Q4 2019 | Q2 2024 | 12 |
FHB | FIRST HAWAIIAN INC | 12 | 12 | 0.02% | 0.08% | 0.12% | Q3 2016 | Q2 2019 | 12 |
HMC | HONDA MOTOR LTD | 11 | 1 | 0.01% | 0.08% | 0.10% | Q3 2016 | Q3 2019 | 12 |
NYLD | NRG YIELD INC | 12 | 12 | 0.00% | 0.05% | 0.08% | Q3 2015 | Q2 2018 | 12 |
ZGNX | ZOGENIX INC | 11 | 11 | 0.35% | 2.30% | 4.17% | Q4 2017 | Q2 2020 | 11 |
MDVN | MEDIVATION INC | 11 | 11 | 0.55% | 1.97% | 3.80% | Q4 2013 | Q2 2016 | 11 |
CBI | CHICAGO BRIDGE & IRON ... | 11 | 11 | 0.95% | 1.49% | 2.65% | Q4 2013 | Q2 2016 | 11 |
DLO | DLOCAL LTD | 11 | 11 | 0.36% | 1.48% | 2.00% | Q3 2021 | Q1 2024 | 11 |
ZI | ZOOMINFO TECHNOLOGIES INC | 11 | 11 | 0.00% | 1.47% | 2.08% | Q3 2020 | Q1 2023 | 11 |
LLTC | LINEAR TECHNOLOGY CORP | 11 | 11 | 0.62% | 1.26% | 2.06% | Q4 2013 | Q2 2016 | 11 |
EOG | EOG RES INC | 9 | 2 | 0.01% | 1.16% | 2.30% | Q4 2013 | Q2 2024 | 11 |
UFS | DOMTAR CORP | 11 | 11 | 0.43% | 1.09% | 2.25% | Q4 2013 | Q2 2016 | 11 |
CAFD | 8POINT3 ENERGY PARTNER... | 11 | 11 | 0.21% | 1.07% | 1.39% | Q3 2015 | Q1 2018 | 11 |
MGTA | MAGENTA THERAPEUTICS INC | 11 | 11 | 0.12% | 0.88% | 1.71% | Q2 2018 | Q4 2020 | 11 |
COUR | COURSERA INC | 11 | 11 | 0.33% | 0.81% | 1.24% | Q3 2021 | Q1 2024 | 11 |
SMAR | SMARTSHEET INC | 11 | 11 | 0.41% | 0.80% | 1.27% | Q3 2019 | Q1 2022 | 11 |
AVRO | AVROBIO INC | 11 | 11 | 0.28% | 0.76% | 1.70% | Q2 2018 | Q4 2020 | 11 |
SHLS | SHOALS TECHNOLOGIES GR... | 11 | 11 | 0.17% | 0.57% | 1.06% | Q1 2021 | Q3 2023 | 11 |
PAYC | PAYCOM SOFTWARE INC | 10 | 1 | 0.01% | 0.54% | 0.98% | Q3 2017 | Q1 2021 | 11 |
ANNX | ANNEXON INC | 11 | 11 | 0.13% | 0.52% | 1.03% | Q3 2020 | Q1 2023 | 11 |
SNDX | SYNDAX PHARMACEUTICALS... | 9 | 2 | 0.08% | 0.29% | 0.67% | Q2 2017 | Q1 2022 | 11 |
ETNB | 89BIO INC | 9 | 2 | 0.12% | 0.27% | 0.44% | Q4 2019 | Q2 2023 | 11 |
PHAT | PHATHOM PHARMACEUTICAL... | 11 | 11 | 0.06% | 0.25% | 0.40% | Q4 2019 | Q2 2022 | 11 |
FRLN | FREELINE THERAPEUTICS ... | 11 | 11 | 0.04% | 0.24% | 0.70% | Q3 2020 | Q1 2023 | 11 |
EGP | EASTGROUP PPTYS INC | 11 | 11 | 0.09% | 0.22% | 0.46% | Q4 2021 | Q2 2024 | 11 |
CDTX | CIDARA THERAPEUTICS INC | 11 | 11 | 0.06% | 0.15% | 0.23% | Q2 2015 | Q4 2017 | 11 |
SNV | SYNOVUS FINL CORP | 8 | 3 | 0.02% | 0.13% | 0.27% | Q1 2021 | Q2 2024 | 11 |
EQIX | EQUINIX INC | 6 | 1 | 0.03% | 0.11% | 0.19% | Q3 2019 | Q1 2024 | 11 |
NEE | NEXTERA ENERGY INC | 6 | 2 | 0.00% | 0.06% | 0.14% | Q2 2019 | Q2 2023 | 11 |
ARTERIS INC | 11 | 11 | 0.03% | 0.04% | 0.05% | Q4 2021 | Q2 2024 | 11 | |
WBK | WESTPAC BKG CORP | 11 | 11 | 0.00% | 0.03% | 0.05% | Q3 2015 | Q1 2018 | 11 |
RHT | RED HAT INC | 10 | 10 | 1.91% | 2.37% | 2.85% | Q4 2013 | Q1 2016 | 10 |
DT | DYNATRACE INC | 10 | 10 | 0.59% | 1.82% | 2.56% | Q4 2019 | Q1 2022 | 10 |
CYBR | CYBERARK SOFTWARE LTD | 10 | 10 | 0.80% | 1.75% | 2.30% | Q2 2015 | Q3 2017 | 10 |
PTLA | PORTOLA PHARMACEUTICAL... | 10 | 10 | 0.45% | 1.18% | 1.48% | Q4 2013 | Q1 2016 | 10 |
VRNS | VARONIS SYS INC | 10 | 10 | 0.42% | 1.11% | 1.96% | Q4 2017 | Q1 2020 | 10 |
LGND | LIGAND PHARMACEUTICALS... | 10 | 10 | 0.43% | 0.96% | 2.18% | Q4 2013 | Q1 2016 | 10 |
DOOR | MASONITE INTL CORP NEW | 10 | 10 | 0.34% | 0.86% | 1.64% | Q3 2016 | Q4 2018 | 10 |
MNTA | MOMENTA PHARMACEUTICAL... | 10 | 10 | 0.34% | 0.70% | 1.07% | Q1 2018 | Q2 2020 | 10 |
COGT | COGENT BIOSCIENCES INC | 9 | 1 | 0.20% | 0.53% | 0.98% | Q4 2021 | Q2 2024 | 10 |
TRGP | TARGA RES CORP | 10 | 10 | 0.04% | 0.50% | 1.13% | Q1 2022 | Q2 2024 | 10 |
REGN | REGENERON PHARMACEUTICALS | 6 | 4 | 0.15% | 0.31% | 0.49% | Q2 2017 | Q4 2020 | 10 |
MSCI | MSCI INC | 5 | 5 | 0.03% | 0.20% | 0.70% | Q2 2020 | Q2 2024 | 10 |
TCON | TRACON PHARMACEUTICALS... | 10 | 10 | 0.13% | 0.20% | 0.28% | Q3 2015 | Q4 2017 | 10 |
SYRS | SYROS PHARMACEUTICALS INC | 10 | 10 | 0.06% | 0.11% | 0.17% | Q2 2016 | Q3 2018 | 10 |
TNDM | TANDEM DIABETES CARE INC | 10 | 10 | 0.04% | 0.11% | 0.18% | Q3 2014 | Q4 2016 | 10 |
RXDX | PROMETHEUS BIOSCIENCES... | 9 | 9 | 0.97% | 1.74% | 3.10% | Q1 2021 | Q1 2023 | 9 |
SYNA | SYNAPTICS INC | 9 | 9 | 1.28% | 1.64% | 1.87% | Q2 2014 | Q2 2016 | 9 |
DATA | TABLEAU SOFTWARE INC | 9 | 9 | 0.81% | 1.57% | 2.14% | Q2 2014 | Q2 2016 | 9 |
FLYW | FLYWIRE CORPORATION | 9 | 9 | 0.05% | 1.50% | 2.33% | Q2 2022 | Q2 2024 | 9 |
SNA | SNAP ON INC | 9 | 9 | 0.62% | 1.25% | 1.79% | Q3 2016 | Q3 2018 | 9 |
ARW | ARROW ELECTRS INC | 9 | 9 | 0.92% | 1.23% | 1.44% | Q2 2016 | Q2 2018 | 9 |
GNRC | GENERAC HLDGS INC | 8 | 1 | 0.00% | 1.18% | 1.76% | Q4 2020 | Q1 2023 | 9 |
SCTY | SOLARCITY CORP | 9 | 9 | 0.52% | 1.06% | 2.00% | Q4 2013 | Q4 2015 | 9 |
EVH | EVOLENT HEALTH INC | 9 | 9 | 0.14% | 1.01% | 1.42% | Q2 2022 | Q2 2024 | 9 |
PRAX | PRAXIS PRECISION MEDIC... | 9 | 9 | 0.16% | 0.94% | 2.82% | Q4 2020 | Q4 2022 | 9 |
LNG | CHENIERE ENERGY INC | 9 | 9 | 0.08% | 0.86% | 1.32% | Q4 2021 | Q4 2023 | 9 |
CLDX | CELLDEX THERAPEUTICS I... | 9 | 9 | 0.14% | 0.66% | 1.92% | Q4 2013 | Q4 2015 | 9 |
PWR | QUANTA SVCS INC | 8 | 1 | 0.33% | 0.63% | 0.93% | Q4 2013 | Q2 2024 | 9 |
CDW | CDW CORP | 9 | 9 | 0.28% | 0.58% | 0.77% | Q2 2022 | Q2 2024 | 9 |
NARI | INARI MED INC | 9 | 9 | 0.09% | 0.50% | 0.85% | Q2 2022 | Q2 2024 | 9 |
OKTA | OKTA INC | 9 | 9 | 0.32% | 0.44% | 0.56% | Q1 2019 | Q1 2021 | 9 |
IRTC | IRHYTHM TECHNOLOGIES INC | 9 | 9 | 0.07% | 0.40% | 0.54% | Q2 2022 | Q2 2024 | 9 |
INSP | INSPIRE MED SYS INC | 9 | 9 | 0.09% | 0.39% | 0.59% | Q2 2022 | Q2 2024 | 9 |
KROS | KEROS THERAPEUTICS INC | 6 | 3 | 0.24% | 0.38% | 0.71% | Q4 2020 | Q2 2024 | 9 |
ALLK | ALLAKOS INC | 8 | 1 | 0.01% | 0.37% | 0.88% | Q3 2018 | Q4 2021 | 9 |
CCXI | CHEMOCENTRYX INC | 9 | 9 | 0.22% | 0.33% | 0.48% | Q2 2020 | Q2 2022 | 9 |
PRVA | PRIVIA HEALTH GROUP INC | 9 | 9 | 0.02% | 0.33% | 0.51% | Q2 2022 | Q2 2024 | 9 |
ICPT | INTERCEPT PHARMACEUTIC... | 6 | 1 | 0.07% | 0.33% | 0.79% | Q4 2018 | Q1 2023 | 9 |
RARX | RA PHARMACEUTICALS INC | 7 | 2 | 0.08% | 0.28% | 0.68% | Q2 2017 | Q3 2019 | 9 |
ESSA PHARMA INC | 9 | 9 | 0.03% | 0.26% | 0.49% | Q1 2016 | Q1 2018 | 9 | |
ROIVANT SCIENCES LTD | 9 | 9 | 0.09% | 0.20% | 0.36% | Q4 2021 | Q4 2023 | 9 | |
CIEN | CIENA CORP | 9 | 9 | 0.03% | 0.20% | 0.31% | Q2 2020 | Q2 2022 | 9 |
TERP | TERRAFORM PWR INC | 5 | 4 | 0.00% | 0.13% | 1.03% | Q3 2015 | Q4 2017 | 9 |
MLHR | MILLER HERMAN INC | 9 | 9 | 0.01% | 0.05% | 0.07% | Q4 2017 | Q4 2019 | 9 |
GLBL | TERRAFORM GLOBAL INC | 9 | 9 | 0.00% | 0.05% | 0.26% | Q3 2015 | Q3 2017 | 9 |
MBBYF | MOBILEYE N V AMSTELVEEN | 8 | 8 | 1.56% | 2.08% | 2.47% | Q1 2015 | Q4 2016 | 8 |
SUNEQ | SUNEDISON INC | 8 | 8 | 1.18% | 1.92% | 2.55% | Q4 2013 | Q3 2015 | 8 |
DYAX | DYAX CORP | 8 | 8 | 1.61% | 1.88% | 2.40% | Q4 2013 | Q3 2015 | 8 |
MIRM | MIRUM PHARMACEUTICALS INC | 8 | 8 | 0.53% | 1.34% | 2.25% | Q3 2022 | Q2 2024 | 8 |
DV | DOUBLEVERIFY HLDGS INC | 8 | 8 | 0.44% | 1.06% | 1.39% | Q3 2022 | Q2 2024 | 8 |
SWAV | SHOCKWAVE MED INC | 8 | 8 | 0.10% | 1.01% | 2.59% | Q2 2022 | Q1 2024 | 8 |
ININ | INTERACTIVE INTELLIGEN... | 8 | 8 | 0.31% | 0.96% | 1.92% | Q4 2013 | Q3 2015 | 8 |
CMRE | COSTAMARE INC | 8 | 8 | 0.26% | 0.78% | 1.20% | Q4 2013 | Q3 2015 | 8 |
SGMO | SANGAMO BIOSCIENCES INC | 8 | 8 | 0.16% | 0.72% | 1.30% | Q4 2013 | Q3 2015 | 8 |
YETI | YETI HLDGS INC | 8 | 8 | 0.21% | 0.60% | 0.85% | Q4 2020 | Q3 2022 | 8 |
BCYC | BICYCLE THERAPEUTICS PLC | 8 | 8 | 0.18% | 0.54% | 0.98% | Q1 2021 | Q4 2022 | 8 |
AYI | ACUITY BRANDS INC | 8 | 8 | 0.02% | 0.54% | 1.50% | Q3 2016 | Q2 2018 | 8 |
KITE | KITE PHARMA INC | 8 | 8 | 0.37% | 0.48% | 0.66% | Q3 2015 | Q2 2017 | 8 |
NRIX | NURIX THERAPEUTICS INC | 8 | 8 | 0.31% | 0.47% | 0.69% | Q3 2020 | Q2 2022 | 8 |
AJG | GALLAGHER ARTHUR J & CO | 8 | 8 | 0.11% | 0.46% | 0.88% | Q3 2022 | Q2 2024 | 8 |
KURA | KURA ONCOLOGY INC | 8 | 8 | 0.20% | 0.43% | 0.70% | Q3 2020 | Q2 2022 | 8 |
BBIO | BRIDGEBIO PHARMA INC | 6 | 2 | 0.27% | 0.41% | 0.65% | Q1 2021 | Q2 2024 | 8 |
VKTX | VIKING THERAPEUTICS INC | 5 | 3 | 0.15% | 0.35% | 0.60% | Q3 2018 | Q2 2024 | 8 |
VECT | VECTIVBIO HLDG AG | 8 | 8 | 0.14% | 0.33% | 0.58% | Q2 2021 | Q1 2023 | 8 |
CSII | CARDIOVASCULAR SYS INC... | 8 | 8 | 0.11% | 0.20% | 0.26% | Q4 2013 | Q3 2015 | 8 |
BCRX | BIOCRYST PHARMACEUTICA... | 3 | 2 | 0.07% | 0.20% | 0.37% | Q2 2017 | Q3 2023 | 8 |
ZSAN | ZOSANO PHARMA CORP | 8 | 8 | 0.01% | 0.19% | 0.63% | Q1 2015 | Q4 2016 | 8 |
TALS | TALARIS THERAPEUTICS INC | 8 | 8 | 0.03% | 0.18% | 0.30% | Q2 2021 | Q1 2023 | 8 |
PALO ALTO NETWORKS INC | 6 | 2 | 0.06% | 0.15% | 0.25% | Q3 2019 | Q1 2022 | 8 | |
ARAY | ACCURAY INC | 4 | 4 | 0.09% | 0.13% | 0.26% | Q1 2015 | Q1 2017 | 8 |
MDSO | MEDIDATA SOLUTIONS INC | 8 | 8 | 0.05% | 0.11% | 0.26% | Q4 2013 | Q3 2015 | 8 |
FHN | FIRST HORIZON NATL CORP | 6 | 2 | 0.04% | 0.11% | 0.22% | Q3 2019 | Q3 2021 | 8 |
HANNON ARMSTRONG SUST ... | 8 | 8 | 0.05% | 0.06% | 0.08% | Q3 2017 | Q2 2019 | 8 | |
WM | WASTE MGMT INC DEL | 6 | 1 | 0.01% | 0.06% | 0.09% | Q2 2019 | Q1 2024 | 8 |
HTGC | HERCULES TECH GROWTH C... | 8 | 8 | 0.01% | 0.06% | 0.10% | Q3 2015 | Q2 2017 | 8 |
CCIPRA | CROWN CASTLE INTL CORP... | 7 | 1 | 0.01% | 0.05% | 0.06% | Q3 2017 | Q1 2020 | 8 |
SLAB | SILICON LABORATORIES INC | 8 | 8 | 0.01% | 0.03% | 0.06% | Q3 2020 | Q2 2022 | 8 |
ACORDA THERAPEUTICS INC | 8 | 8 | 0.01% | 0.02% | 0.02% | Q2 2017 | Q1 2019 | 8 | |
NVDA | NVIDIA CORPORATION | 7 | 1 | 0.00% | 0.01% | 0.04% | Q3 2019 | Q2 2024 | 8 |
CMRX | CHIMERIX INC | 7 | 7 | 1.19% | 1.41% | 1.84% | Q1 2014 | Q3 2015 | 7 |
NRG | NRG ENERGY INC | 7 | 7 | 0.96% | 1.28% | 1.71% | Q4 2013 | Q2 2015 | 7 |
PLRX | PLIANT THERAPEUTICS INC | 7 | 7 | 0.01% | 1.00% | 1.92% | Q2 2020 | Q4 2021 | 7 |
TMDX | TRANSMEDICS GROUP INC | 5 | 2 | 0.03% | 0.95% | 2.95% | Q2 2021 | Q2 2024 | 7 |
RNG | RINGCENTRAL INC | 7 | 7 | 0.42% | 0.93% | 1.26% | Q1 2020 | Q3 2021 | 7 |
ZYME | ZYMEWORKS INC | 7 | 7 | 0.55% | 0.85% | 1.49% | Q1 2021 | Q3 2022 | 7 |
ANET | ARISTA NETWORKS INC | 7 | 7 | 0.64% | 0.84% | 1.27% | Q1 2018 | Q3 2019 | 7 |
VITL | VITAL FARMS INC | 7 | 7 | 0.18% | 0.65% | 0.97% | Q4 2020 | Q2 2022 | 7 |
AURA BIOSCIENCES INC | 7 | 7 | 0.43% | 0.61% | 0.84% | Q4 2022 | Q2 2024 | 7 | |
RPRX | ROYALTY PHARMA PLC | 7 | 7 | 0.24% | 0.46% | 0.69% | Q4 2022 | Q2 2024 | 7 |
ORLY | OREILLY AUTOMOTIVE INC | 7 | 7 | 0.00% | 0.45% | 0.60% | Q4 2022 | Q2 2024 | 7 |
SWKS | SKYWORKS SOLUTIONS INC | 7 | 7 | 0.33% | 0.40% | 0.45% | Q1 2020 | Q3 2021 | 7 |
CYTK | CYTOKINETICS INC | 7 | 7 | 0.24% | 0.39% | 0.76% | Q4 2022 | Q2 2024 | 7 |
APLS | APELLIS PHARMACEUTICAL... | 4 | 3 | 0.14% | 0.36% | 0.61% | Q3 2022 | Q2 2024 | 7 |
CSLT | CASTLIGHT HEALTH INC | 7 | 7 | 0.19% | 0.33% | 0.43% | Q2 2015 | Q4 2016 | 7 |
WDAY | WORKDAY INC | 7 | 7 | 0.01% | 0.30% | 0.51% | Q4 2022 | Q2 2024 | 7 |
WEC | WEC ENERGY GROUP INC | 5 | 2 | 0.06% | 0.24% | 0.41% | Q1 2020 | Q1 2023 | 7 |
SAAS | INCONTACT INC | 7 | 7 | 0.08% | 0.24% | 0.46% | Q4 2013 | Q2 2015 | 7 |
ACRS | ACLARIS THERAPEUTICS INC | 7 | 7 | 0.12% | 0.23% | 0.39% | Q3 2016 | Q1 2018 | 7 |
EPZM | EPIZYME INC | 7 | 7 | 0.16% | 0.23% | 0.31% | Q1 2016 | Q3 2017 | 7 |
AESC | AES CORP | 7 | 7 | 0.12% | 0.23% | 0.34% | Q2 2021 | Q4 2022 | 7 |
LW | LAMB WESTON HLDGS INC | 7 | 7 | 0.02% | 0.22% | 0.45% | Q3 2019 | Q1 2021 | 7 |
SNSS | SUNESIS PHARMACEUTICAL... | 7 | 7 | 0.00% | 0.20% | 0.44% | Q3 2017 | Q1 2019 | 7 |
CHRS | COHERUS BIOSCIENCES INC | 7 | 7 | 0.11% | 0.18% | 0.27% | Q1 2016 | Q3 2017 | 7 |
IRWD | IRONWOOD PHARMACEUTICA... | 6 | 1 | 0.13% | 0.16% | 0.23% | Q2 2017 | Q4 2023 | 7 |
DERM | DERMIRA INC | 7 | 7 | 0.11% | 0.16% | 0.22% | Q2 2017 | Q4 2018 | 7 |
FEIC | FEI CO | 7 | 7 | 0.07% | 0.15% | 0.24% | Q4 2013 | Q2 2015 | 7 |
PTCT | PTC THERAPEUTICS INC | 6 | 1 | 0.03% | 0.13% | 0.42% | Q3 2017 | Q1 2023 | 7 |
CTMX | CYTOMX THERAPEUTICS INC | 7 | 7 | 0.09% | 0.12% | 0.17% | Q4 2015 | Q2 2017 | 7 |
IMDZ | IMMUNE DESIGN CORP | 7 | 7 | 0.08% | 0.12% | 0.18% | Q1 2015 | Q3 2016 | 7 |
XOMA | XOMA CORP DEL | 7 | 7 | 0.03% | 0.12% | 0.25% | Q4 2013 | Q2 2015 | 7 |
PHVS | PHARVARIS N V | 7 | 7 | 0.05% | 0.12% | 0.21% | Q1 2021 | Q3 2022 | 7 |
GRMN | GARMIN LTD | 7 | 7 | 0.04% | 0.09% | 0.12% | Q4 2020 | Q2 2022 | 7 |
AWK | AMERICAN WTR WKS CO IN... | 7 | 7 | 0.07% | 0.08% | 0.10% | Q2 2020 | Q4 2021 | 7 |
JKHY | HENRY JACK & ASSOC INC | 7 | 7 | 0.04% | 0.07% | 0.11% | Q1 2020 | Q3 2021 | 7 |
TERP | TERRAFORM PWR INC | 7 | 7 | 0.04% | 0.07% | 0.09% | Q1 2018 | Q3 2019 | 7 |
RPTP | RAPTOR PHARMACEUTICAL ... | 7 | 7 | 0.01% | 0.06% | 0.16% | Q4 2013 | Q2 2015 | 7 |
NEUROCRINE BIOSCIENCES... | 7 | 7 | 0.02% | 0.05% | 0.06% | Q3 2019 | Q1 2021 | 7 | |
OM | OUTSET MED INC | 7 | 7 | 0.01% | 0.03% | 0.05% | Q3 2020 | Q1 2022 | 7 |
NOW | SERVICENOW INC | 7 | 7 | 0.00% | 0.01% | 0.03% | Q4 2022 | Q2 2024 | 7 |
FVRR | FIVERR INTL LTD | 6 | 6 | 0.64% | 1.46% | 1.76% | Q2 2020 | Q3 2021 | 6 |
HZNP | HORIZON THERAPEUTICS P... | 6 | 6 | 0.12% | 1.30% | 2.24% | Q2 2022 | Q3 2023 | 6 |
TEX | TEREX CORP NEW | 6 | 6 | 0.70% | 1.24% | 2.09% | Q1 2014 | Q2 2015 | 6 |
LAD | LITHIA MTRS INC | 6 | 6 | 0.53% | 1.15% | 1.44% | Q1 2023 | Q2 2024 | 6 |
OII | OCEANEERING INTL INC | 6 | 6 | 0.53% | 1.09% | 1.99% | Q4 2013 | Q1 2015 | 6 |
TRILLIUM THERAPEUTICS INC | 6 | 6 | 0.45% | 1.01% | 1.24% | Q2 2020 | Q3 2021 | 6 | |
FC | FRANKLIN COVEY CO | 6 | 6 | 0.33% | 0.89% | 1.66% | Q4 2013 | Q1 2015 | 6 |
NLNK | NEWLINK GENETICS CORP | 6 | 6 | 0.64% | 0.88% | 1.07% | Q4 2013 | Q1 2015 | 6 |
MNDY | MONDAY COM LTD | 4 | 2 | 0.04% | 0.78% | 1.42% | Q1 2022 | Q2 2024 | 6 |
TPTX | TURNING POINT THERAPEU... | 6 | 6 | 0.51% | 0.68% | 1.09% | Q2 2020 | Q3 2021 | 6 |
ENPH | ENPHASE ENERGY INC | 6 | 6 | 0.16% | 0.62% | 0.89% | Q4 2021 | Q1 2023 | 6 |
AZPN | ASPEN TECHNOLOGY INC | 6 | 6 | 0.20% | 0.54% | 0.84% | Q1 2014 | Q2 2015 | 6 |
MARINUS PHARMACEUTICAL... | 6 | 6 | 0.25% | 0.50% | 0.80% | Q4 2022 | Q1 2024 | 6 | |
KALA | KALA PHARMACEUTICALS INC | 5 | 1 | 0.08% | 0.49% | 0.84% | Q3 2017 | Q1 2021 | 6 |
IFRX | INFLARX NV | 6 | 6 | 0.30% | 0.36% | 0.44% | Q4 2017 | Q1 2019 | 6 |
ANAB | ANAPTYSBIO INC | 4 | 2 | 0.14% | 0.31% | 0.96% | Q2 2018 | Q2 2024 | 6 |
ARYAU | ARYA SCIENCES ACQUISIT... | 6 | 6 | 0.26% | 0.29% | 0.36% | Q4 2018 | Q1 2020 | 6 |
NTLA | INTELLIA THERAPEUTICS INC | 6 | 6 | 0.18% | 0.27% | 0.35% | Q3 2022 | Q4 2023 | 6 |
CERE | CEREVEL THERAPEUTICS H... | 6 | 6 | 0.14% | 0.27% | 0.34% | Q1 2023 | Q2 2024 | 6 |
R1 RCM INC | 6 | 6 | 0.16% | 0.23% | 0.30% | Q1 2023 | Q2 2024 | 6 | |
VBIV | VBI VACCINES INC | 6 | 6 | 0.12% | 0.22% | 0.41% | Q4 2017 | Q1 2019 | 6 |
BEAM | BEAM THERAPEUTICS INC | 6 | 6 | 0.11% | 0.20% | 0.26% | Q3 2022 | Q4 2023 | 6 |
EHC | ENCOMPASS HEALTH CORP | 6 | 6 | 0.16% | 0.20% | 0.23% | Q3 2022 | Q4 2023 | 6 |
JUNO | JUNO THERAPEUTICS INC | 6 | 6 | 0.11% | 0.17% | 0.21% | Q4 2015 | Q1 2017 | 6 |
PCRX | PACIRA PHARMACEUTICALS... | 6 | 6 | 0.09% | 0.16% | 0.24% | Q4 2013 | Q1 2015 | 6 |
AQXP | AQUINOX PHARMACEUTICAL... | 6 | 6 | 0.11% | 0.15% | 0.19% | Q4 2016 | Q1 2018 | 6 |
ORTX | ORCHARD THERAPEUTICS PLC | 6 | 6 | 0.07% | 0.12% | 0.19% | Q4 2018 | Q1 2020 | 6 |
DSGN | DESIGN THERAPEUTICS INC | 6 | 6 | 0.08% | 0.11% | 0.18% | Q1 2021 | Q2 2022 | 6 |
INFI | INFINITY PHARMACEUTICA... | 6 | 6 | 0.07% | 0.11% | 0.18% | Q4 2014 | Q1 2016 | 6 |
CBIO | CATALYST BIOSCIENCES INC | 6 | 6 | 0.08% | 0.10% | 0.13% | Q2 2018 | Q3 2019 | 6 |
TFX | TELEFLEX INC | 6 | 6 | 0.05% | 0.09% | 0.17% | Q4 2013 | Q1 2015 | 6 |
RCUS | ARCUS BIOSCIENCES INC | 6 | 6 | 0.07% | 0.08% | 0.10% | Q4 2022 | Q1 2024 | 6 |
FOUR | SHIFT4 PMTS INC | 6 | 6 | 0.04% | 0.06% | 0.07% | Q4 2020 | Q1 2022 | 6 |
ZBH | ZIMMER BIOMET HOLDINGS... | 6 | 6 | 0.05% | 0.05% | 0.07% | Q4 2019 | Q1 2021 | 6 |
IR | INGERSOLL-RAND PLC | 4 | 2 | 0.02% | 0.05% | 0.08% | Q2 2018 | Q4 2019 | 6 |
CVA | COVANTA HLDG CORP | 6 | 6 | 0.02% | 0.04% | 0.05% | Q4 2017 | Q1 2019 | 6 |
GPMT | GRANITE PT MTG TR INC | 5 | 1 | 0.01% | 0.04% | 0.06% | Q1 2018 | Q3 2019 | 6 |
NXPI | NXP SEMICONDUCTORS N V | 3 | 1 | 0.00% | 0.03% | 0.05% | Q1 2019 | Q4 2022 | 6 |
CIG | COMPANHIA ENERGETICA D... | 6 | 6 | 0.01% | 0.03% | 0.04% | Q4 2017 | Q1 2019 | 6 |
BBN | BLACKROCK TAX MUNICPAL... | 6 | 6 | 0.01% | 0.02% | 0.02% | Q3 2015 | Q4 2016 | 6 |
NSC | NORFOLK SOUTHERN CORP | 6 | 6 | 0.01% | 0.01% | 0.02% | Q3 2015 | Q4 2016 | 6 |
TRW | TRW AUTOMOTIVE HLDGS CORP | 5 | 5 | 2.23% | 2.48% | 2.80% | Q4 2013 | Q4 2014 | 5 |
DOCS | DOXIMITY INC | 5 | 5 | 1.13% | 2.22% | 3.12% | Q2 2022 | Q2 2023 | 5 |
AVXS | AVEXIS INC | 5 | 5 | 0.41% | 1.77% | 2.44% | Q1 2017 | Q1 2018 | 5 |
MEOH | METHANEX CORP | 5 | 5 | 1.01% | 1.76% | 2.21% | Q4 2013 | Q4 2014 | 5 |
XYL | XYLEM INC | 5 | 5 | 1.08% | 1.66% | 2.07% | Q1 2019 | Q1 2020 | 5 |
LYB | LYONDELLBASELL INDUSTR... | 5 | 5 | 1.16% | 1.66% | 2.04% | Q4 2013 | Q4 2014 | 5 |
PCYC | PHARMACYCLICS INC | 5 | 5 | 1.01% | 1.47% | 2.17% | Q4 2013 | Q4 2014 | 5 |
CCI | CROWN CASTLE INTL CORP | 5 | 5 | 1.01% | 1.28% | 1.50% | Q4 2013 | Q4 2014 | 5 |
P103PS | NPS PHARMACEUTICALS INC | 5 | 5 | 0.81% | 1.26% | 2.27% | Q4 2013 | Q4 2014 | 5 |
CXP | COLUMBIA PPTY TR INC | 5 | 5 | 0.80% | 1.20% | 1.42% | Q1 2014 | Q1 2015 | 5 |
TOAST INC | 5 | 5 | 0.61% | 1.08% | 1.43% | Q2 2023 | Q2 2024 | 5 | |
VMW | VMWARE INC | 5 | 5 | 0.60% | 1.07% | 1.32% | Q1 2014 | Q1 2015 | 5 |
IMMU | IMMUNOMEDICS INC | 5 | 5 | 0.41% | 0.69% | 0.93% | Q2 2018 | Q2 2019 | 5 |
GTTN | GTT COMMUNICATIONS INC | 5 | 5 | 0.10% | 0.58% | 1.17% | Q4 2017 | Q4 2018 | 5 |
FOLD | AMICUS THERAPEUTICS INC | 5 | 5 | 0.31% | 0.58% | 0.76% | Q3 2018 | Q3 2019 | 5 |
SGEN | SEAGEN INC | 4 | 1 | 0.28% | 0.57% | 1.04% | Q4 2020 | Q3 2023 | 5 |
REXR | REXFORD INDL RLTY INC | 5 | 5 | 0.14% | 0.45% | 0.70% | Q3 2021 | Q3 2022 | 5 |
CGEM | CULLINAN ONCOLOGY INC | 5 | 5 | 0.24% | 0.43% | 0.73% | Q1 2021 | Q1 2022 | 5 |
BILL | BILL HOLDINGS INC | 3 | 2 | 0.03% | 0.41% | 0.70% | Q3 2022 | Q4 2023 | 5 |
MAX | MEDIAALPHA INC | 5 | 5 | 0.04% | 0.35% | 0.67% | Q4 2020 | Q4 2021 | 5 |
ECYT | ENDOCYTE INC | 3 | 2 | 0.15% | 0.34% | 0.86% | Q4 2013 | Q3 2018 | 5 |
EIDX | EIDOS THERAPEUTICS INC | 4 | 1 | 0.14% | 0.33% | 0.64% | Q2 2018 | Q4 2020 | 5 |
AMYLYX PHARMACEUTICALS... | 5 | 5 | 0.18% | 0.29% | 0.41% | Q4 2022 | Q4 2023 | 5 | |
SLXP | SALIX PHARMACEUTICALS INC | 5 | 5 | 0.15% | 0.27% | 0.37% | Q4 2013 | Q4 2014 | 5 |
IMGN | IMMUNOGEN INC | 3 | 2 | 0.08% | 0.26% | 0.42% | Q4 2021 | Q4 2023 | 5 |
FANG | DIAMONDBACK ENERGY INC | 5 | 5 | 0.13% | 0.26% | 0.47% | Q2 2023 | Q2 2024 | 5 |
DCPH | DECIPHERA PHARMACEUTIC... | 4 | 1 | 0.18% | 0.26% | 0.32% | Q1 2020 | Q3 2021 | 5 |
HPTX | HYPERION THERAPEUTICS INC | 5 | 5 | 0.19% | 0.24% | 0.29% | Q4 2013 | Q4 2014 | 5 |
MCRB | SERES THERAPEUTICS INC | 5 | 5 | 0.13% | 0.24% | 0.32% | Q3 2015 | Q3 2016 | 5 |
RVMD | REVOLUTION MEDICINES INC | 5 | 5 | 0.16% | 0.23% | 0.43% | Q2 2023 | Q2 2024 | 5 |
KNSA | KINIKSA PHARMACEUTICAL... | 5 | 5 | 0.02% | 0.22% | 0.40% | Q2 2018 | Q2 2019 | 5 |
COMP | COMPASS INC | 3 | 2 | 0.01% | 0.21% | 0.54% | Q2 2021 | Q3 2023 | 5 |
KPTI | KARYOPHARM THERAPEUTIC... | 5 | 5 | 0.12% | 0.20% | 0.32% | Q4 2013 | Q4 2014 | 5 |
CRDF | CARDIFF ONCOLOGY INC | 5 | 5 | 0.06% | 0.18% | 0.32% | Q1 2021 | Q1 2022 | 5 |
ACRX | ACELRX PHARMACEUTICALS... | 5 | 5 | 0.10% | 0.17% | 0.26% | Q4 2013 | Q4 2014 | 5 |
ALXO | ALX ONCOLOGY HLDGS INC | 3 | 2 | 0.06% | 0.17% | 0.32% | Q1 2021 | Q1 2023 | 5 |
LOB | LIVE OAK BANCSHARES INC | 5 | 5 | 0.05% | 0.15% | 0.30% | Q2 2021 | Q2 2022 | 5 |
MEIP | MEI PHARMA INC | 5 | 5 | 0.01% | 0.15% | 0.24% | Q4 2013 | Q4 2014 | 5 |
PTGX | PROTAGONIST THERAPEUTI... | 3 | 2 | 0.09% | 0.15% | 0.30% | Q2 2017 | Q3 2023 | 5 |
PTI | PROTEOSTASIS THERAPEUT... | 5 | 5 | 0.06% | 0.14% | 0.21% | Q1 2016 | Q1 2017 | 5 |
SBNY | SIGNATURE BK NEW YORK N Y | 5 | 5 | 0.05% | 0.13% | 0.20% | Q4 2020 | Q4 2021 | 5 |
SBAC | SBA COMMUNICATIONS COR... | 5 | 5 | 0.07% | 0.10% | 0.15% | Q4 2020 | Q4 2021 | 5 |
BOLT | BOLT BIOTHERAPEUTICS INC | 5 | 5 | 0.04% | 0.10% | 0.16% | Q1 2021 | Q1 2022 | 5 |
RGLS | REGULUS THERAPEUTICS INC | 5 | 5 | 0.06% | 0.10% | 0.15% | Q4 2014 | Q4 2015 | 5 |
IONS | IONIS PHARMACEUTICALS INC | 5 | 5 | 0.07% | 0.08% | 0.10% | Q2 2022 | Q2 2023 | 5 |
WMS | ADVANCED DRAIN SYS INC... | 5 | 5 | 0.02% | 0.08% | 0.11% | Q3 2021 | Q3 2022 | 5 |
KBH | KB HOME | 5 | 5 | 0.02% | 0.07% | 0.09% | Q2 2021 | Q2 2022 | 5 |
EXACT SCIENCES CORP | 5 | 5 | 0.03% | 0.06% | 0.07% | Q1 2020 | Q1 2021 | 5 | |
CPPL | COLUMBIA PIPELINE PART... | 5 | 5 | 0.01% | 0.03% | 0.06% | Q4 2015 | Q4 2016 | 5 |
VSTM | VERASTEM INC | 5 | 5 | 0.00% | 0.02% | 0.03% | Q2 2014 | Q2 2015 | 5 |
DOCU | DOCUSIGN INC | 5 | 5 | 0.01% | 0.02% | 0.02% | Q3 2020 | Q3 2021 | 5 |
EW | EDWARDS LIFESCIENCES CORP | 5 | 5 | 0.00% | 0.01% | 0.01% | Q4 2022 | Q4 2023 | 5 |
QLIK | QLIK TECHNOLOGIES INC | 4 | 4 | 0.99% | 1.57% | 2.08% | Q2 2015 | Q1 2016 | 4 |
KNBE | KNOWBE4 INC | 4 | 4 | 0.85% | 1.28% | 1.52% | Q4 2021 | Q3 2022 | 4 |
SPWR | SUNPOWER CORP | 4 | 4 | 0.75% | 1.11% | 1.50% | Q3 2015 | Q2 2016 | 4 |
ELLI | ELLIE MAE INC | 4 | 4 | 1.04% | 1.08% | 1.13% | Q3 2017 | Q2 2018 | 4 |
IMPV | IMPERVA INC | 4 | 4 | 0.91% | 1.08% | 1.21% | Q2 2015 | Q1 2016 | 4 |
PCVX | VAXCYTE INC | 4 | 4 | 0.36% | 0.66% | 0.96% | Q3 2023 | Q2 2024 | 4 |
AXSM | AXSOME THERAPEUTICS INC | 4 | 4 | 0.43% | 0.65% | 1.29% | Q3 2023 | Q2 2024 | 4 |
ARDX | ARDELYX INC | 4 | 4 | 0.20% | 0.63% | 0.85% | Q3 2023 | Q2 2024 | 4 |
ORA | ORMAT TECHNOLOGIES INC | 4 | 4 | 0.27% | 0.62% | 0.82% | Q4 2015 | Q3 2016 | 4 |
BIOHAVEN LTD | 3 | 1 | 0.28% | 0.62% | 1.47% | Q3 2022 | Q2 2024 | 4 | |
DICE THERAPEUTICS INC | 4 | 4 | 0.44% | 0.59% | 0.78% | Q3 2021 | Q2 2022 | 4 | |
FERG | FERGUSON PLC NEW | 4 | 4 | 0.43% | 0.58% | 0.70% | Q3 2023 | Q2 2024 | 4 |
PBYI | PUMA BIOTECHNOLOGY INC | 2 | 2 | 0.10% | 0.58% | 1.34% | Q4 2013 | Q4 2017 | 4 |
SZYM | SOLAZYME INC | 4 | 4 | 0.20% | 0.57% | 0.81% | Q4 2013 | Q3 2014 | 4 |
STSA | SATSUMA PHARMACEUTICAL... | 4 | 4 | 0.21% | 0.43% | 0.67% | Q3 2019 | Q2 2020 | 4 |
HLI | HOULIHAN LOKEY INC | 4 | 4 | 0.29% | 0.41% | 0.54% | Q3 2023 | Q2 2024 | 4 |
SLDB | SOLID BIOSCIENCES INC | 3 | 1 | 0.09% | 0.38% | 0.69% | Q1 2018 | Q1 2021 | 4 |
ALV | AUTOLIV INC | 4 | 4 | 0.02% | 0.35% | 0.54% | Q3 2023 | Q2 2024 | 4 |
VST | VISTRA CORP | 4 | 4 | 0.07% | 0.35% | 0.73% | Q3 2023 | Q2 2024 | 4 |
VRNA | VERONA PHARMA PLC | 4 | 4 | 0.13% | 0.34% | 0.55% | Q3 2023 | Q2 2024 | 4 |
INZY | INOZYME PHARMA INC | 4 | 4 | 0.22% | 0.28% | 0.38% | Q3 2023 | Q2 2024 | 4 |
CBST | CUBIST PHARMACEUTICALS... | 4 | 4 | 0.25% | 0.28% | 0.31% | Q4 2013 | Q3 2014 | 4 |
THOR | SYNTHORX INC | 4 | 4 | 0.16% | 0.24% | 0.31% | Q4 2018 | Q3 2019 | 4 |
MKC | MCCORMICK & CO INC | 4 | 4 | 0.19% | 0.23% | 0.27% | Q1 2020 | Q4 2020 | 4 |
ARVN | ARVINAS INC | 3 | 1 | 0.11% | 0.20% | 0.30% | Q1 2020 | Q3 2022 | 4 |
IDYA | IDEAYA BIOSCIENCES INC | 4 | 4 | 0.16% | 0.20% | 0.23% | Q3 2023 | Q2 2024 | 4 |
ORIC | ORIC PHARMACEUTICALS INC | 4 | 4 | 0.16% | 0.20% | 0.22% | Q4 2020 | Q3 2021 | 4 |
UROV | UROVANT SCIENCES LTD | 4 | 4 | 0.10% | 0.20% | 0.26% | Q3 2018 | Q2 2019 | 4 |
ACHN | ACHILLION PHARMACEUTIC... | 4 | 4 | 0.13% | 0.19% | 0.24% | Q1 2017 | Q4 2017 | 4 |
WD | WALKER & DUNLOP INC | 4 | 4 | 0.15% | 0.19% | 0.25% | Q1 2022 | Q4 2022 | 4 |
CHMA | CHIASMA INC | 4 | 4 | 0.11% | 0.18% | 0.25% | Q2 2020 | Q1 2021 | 4 |
GPI | GROUP 1 AUTOMOTIVE INC | 4 | 4 | 0.08% | 0.15% | 0.21% | Q3 2023 | Q2 2024 | 4 |
DLPH | DELPHI TECHNOLOGIES PLC | 4 | 4 | 0.06% | 0.11% | 0.14% | Q4 2017 | Q3 2018 | 4 |
SNSS | SUNESIS PHARMACEUTICAL... | 4 | 4 | 0.08% | 0.10% | 0.13% | Q4 2013 | Q3 2014 | 4 |
VFC | V F CORP | 4 | 4 | 0.03% | 0.08% | 0.10% | Q4 2020 | Q3 2021 | 4 |
EXACT SCIENCES CORP | 4 | 4 | 0.04% | 0.07% | 0.14% | Q1 2021 | Q4 2021 | 4 | |
LINDE PLC | 4 | 4 | 0.01% | 0.05% | 0.10% | Q3 2023 | Q2 2024 | 4 | |
SPGI | S&P GLOBAL INC | 4 | 4 | 0.02% | 0.05% | 0.08% | Q3 2023 | Q2 2024 | 4 |
GUARDANT HEALTH INC | 4 | 4 | 0.04% | 0.04% | 0.04% | Q4 2021 | Q3 2022 | 4 | |
TURNSTONE BIOLOGICS CORP | 4 | 4 | 0.02% | 0.03% | 0.05% | Q3 2023 | Q2 2024 | 4 | |
DERMIRA INC | 4 | 4 | 0.02% | 0.03% | 0.04% | Q2 2018 | Q1 2019 | 4 | |
NOK | NOKIA CORP | 4 | 4 | 0.01% | 0.03% | 0.05% | Q4 2018 | Q3 2019 | 4 |
MEDICINES CO | 4 | 4 | 0.02% | 0.02% | 0.04% | Q4 2018 | Q3 2019 | 4 | |
JCI | JOHNSON CTLS INC | 4 | 4 | 0.01% | 0.02% | 0.04% | Q3 2015 | Q2 2016 | 4 |
PSA | PUBLIC STORAGE | 4 | 4 | 0.02% | 0.02% | 0.02% | Q2 2018 | Q1 2019 | 4 |
BAB | POWERSHARES ETF TR II | 4 | 4 | 0.01% | 0.01% | 0.01% | Q3 2015 | Q2 2016 | 4 |
HERCULES CAPITAL INC | 4 | 4 | 0.01% | 0.01% | 0.01% | Q1 2018 | Q4 2018 | 4 | |
NATI | NATIONAL INSTRS CORP | 4 | 4 | 0.00% | 0.00% | 0.01% | Q3 2015 | Q2 2016 | 4 |
IGV | ISHARES TR | 3 | 3 | 2.01% | 2.40% | 2.99% | Q1 2020 | Q3 2020 | 3 |
FEYE | FIREEYE INC | 3 | 3 | 1.94% | 2.04% | 2.19% | Q4 2014 | Q2 2015 | 3 |
TRN | TRINITY INDS INC | 3 | 3 | 1.31% | 1.77% | 2.44% | Q4 2014 | Q2 2015 | 3 |
SDRL | SEADRILL LIMITED | 3 | 3 | 1.20% | 1.42% | 1.81% | Q4 2013 | Q2 2014 | 3 |
ALTR | ALTAIR ENGR INC | 3 | 3 | 0.80% | 1.20% | 1.60% | Q3 2018 | Q1 2019 | 3 |
JELD | JELD-WEN HLDG INC | 3 | 3 | 0.83% | 0.93% | 1.04% | Q4 2017 | Q2 2018 | 3 |
WSO | WATSCO INC | 3 | 3 | 0.77% | 0.83% | 0.87% | Q3 2016 | Q1 2017 | 3 |
LEXEO THERAPEUTICS INC | 3 | 3 | 0.66% | 0.80% | 0.92% | Q4 2023 | Q2 2024 | 3 | |
IAA | IAA INC | 3 | 3 | 0.72% | 0.79% | 0.84% | Q2 2019 | Q4 2019 | 3 |
FSLR | FIRST SOLAR INC | 2 | 1 | 0.21% | 0.76% | 1.68% | Q1 2016 | Q2 2024 | 3 |
TLND | TALEND S A | 3 | 3 | 0.64% | 0.71% | 0.81% | Q4 2018 | Q2 2019 | 3 |
CSIQ | CANADIAN SOLAR INC | 3 | 3 | 0.56% | 0.69% | 0.87% | Q4 2015 | Q2 2016 | 3 |
KDNY | CHINOOK THERAPEUTICS INC | 3 | 3 | 0.19% | 0.68% | 1.25% | Q4 2022 | Q2 2023 | 3 |
NCNO | NCINO INC | 3 | 3 | 0.48% | 0.55% | 0.62% | Q2 2021 | Q4 2021 | 3 |
ABY | ABENGOA YIELD PLC | 3 | 3 | 0.00% | 0.51% | 0.90% | Q3 2015 | Q1 2016 | 3 |
KORRO BIO INC | 3 | 3 | 0.31% | 0.50% | 0.76% | Q4 2023 | Q2 2024 | 3 | |
DUOLINGO INC | 3 | 3 | 0.35% | 0.48% | 0.71% | Q4 2021 | Q2 2022 | 3 | |
AKCA | AKCEA THERAPEUTICS INC | 3 | 3 | 0.21% | 0.42% | 0.66% | Q3 2017 | Q1 2018 | 3 |
SRRK | SCHOLAR ROCK HLDG CORP | 3 | 3 | 0.30% | 0.39% | 0.44% | Q4 2023 | Q2 2024 | 3 |
KRYS | KRYSTAL BIOTECH INC | 3 | 3 | 0.28% | 0.36% | 0.43% | Q4 2023 | Q2 2024 | 3 |
AKRO | AKERO THERAPEUTICS INC | 3 | 3 | 0.27% | 0.34% | 0.47% | Q1 2023 | Q3 2023 | 3 |
MDCO | MEDICINES CO | 3 | 3 | 0.28% | 0.33% | 0.37% | Q4 2018 | Q2 2019 | 3 |
SHC | SOTERA HEALTH CO | 3 | 3 | 0.28% | 0.32% | 0.37% | Q4 2020 | Q2 2021 | 3 |
MDGL | MADRIGAL PHARMACEUTICA... | 3 | 3 | 0.14% | 0.31% | 0.53% | Q1 2018 | Q3 2018 | 3 |
BYND | BEYOND MEAT INC | 3 | 3 | 0.21% | 0.28% | 0.32% | Q1 2021 | Q3 2021 | 3 |
COG | COTERRA ENERGY INC | 2 | 1 | 0.18% | 0.27% | 0.42% | Q4 2013 | Q2 2024 | 3 |
BFLY | BUTTERFLY NETWORK INC | 3 | 3 | 0.24% | 0.26% | 0.28% | Q1 2021 | Q3 2021 | 3 |
SO | SOUTHERN CO | 3 | 3 | 0.19% | 0.26% | 0.39% | Q4 2023 | Q2 2024 | 3 |
BAX | BAXTER INTL INC | 3 | 3 | 0.20% | 0.23% | 0.27% | Q2 2022 | Q4 2022 | 3 |
SBTX | SILVERBACK THERAPEUTIC... | 3 | 3 | 0.15% | 0.21% | 0.24% | Q4 2020 | Q2 2021 | 3 |
ADVM | ADVERUM BIOTECHNOLOGIE... | 3 | 3 | 0.16% | 0.21% | 0.26% | Q4 2018 | Q2 2019 | 3 |
APTVPRA | APTIV PLC | 2 | 1 | 0.15% | 0.19% | 0.21% | Q4 2021 | Q3 2022 | 3 |
AMBI | AMBIT BIOSCIENCES CORP | 3 | 3 | 0.14% | 0.18% | 0.22% | Q4 2013 | Q2 2014 | 3 |
APTVPRA | APTIV PLC | 2 | 1 | 0.17% | 0.18% | 0.20% | Q1 2022 | Q1 2023 | 3 |
DNLI | DENALI THERAPEUTICS INC | 3 | 3 | 0.13% | 0.17% | 0.23% | Q1 2023 | Q3 2023 | 3 |
ARWR | ARROWHEAD PHARMACEUTIC... | 3 | 3 | 0.14% | 0.17% | 0.21% | Q4 2023 | Q2 2024 | 3 |
APTOSE BIOSCIENCES INC | 3 | 3 | 0.10% | 0.15% | 0.20% | Q4 2020 | Q2 2021 | 3 | |
EQT | EQT CORP | 2 | 1 | 0.07% | 0.14% | 0.23% | Q3 2022 | Q3 2023 | 3 |
CBT | CABOT CORP | 3 | 3 | 0.11% | 0.14% | 0.16% | Q4 2023 | Q2 2024 | 3 |
AAVL | AVALANCHE BIOTECHNOLOG... | 3 | 3 | 0.10% | 0.13% | 0.19% | Q3 2014 | Q1 2015 | 3 |
ITT | ITT INC | 3 | 3 | 0.08% | 0.11% | 0.14% | Q2 2020 | Q4 2020 | 3 |
SRE | SEMPRA | 3 | 3 | 0.09% | 0.11% | 0.14% | Q4 2023 | Q2 2024 | 3 |
FIVN | FIVE9 INC | 2 | 1 | 0.00% | 0.10% | 0.26% | Q3 2021 | Q2 2024 | 3 |
VICL | VICAL INC | 3 | 3 | 0.01% | 0.10% | 0.16% | Q4 2017 | Q2 2018 | 3 |
AQNU | ALGONQUIN PWR UTILS CORP | 3 | 3 | 0.08% | 0.09% | 0.09% | Q2 2021 | Q4 2021 | 3 |
PNFP | PINNACLE FINL PARTNERS... | 3 | 3 | 0.06% | 0.08% | 0.12% | Q4 2023 | Q2 2024 | 3 |
PCOR | PROCORE TECHNOLOGIES INC | 3 | 3 | 0.05% | 0.06% | 0.06% | Q4 2023 | Q2 2024 | 3 |
TER | TERADYNE INC | 3 | 3 | 0.02% | 0.05% | 0.08% | Q4 2019 | Q2 2020 | 3 |
VYNE THERAPEUTICS INC | 3 | 3 | 0.05% | 0.05% | 0.05% | Q4 2023 | Q2 2024 | 3 | |
HCP | HCP INC | 2 | 1 | 0.00% | 0.05% | 0.09% | Q3 2015 | Q3 2019 | 3 |
INTA | INTAPP INC | 3 | 3 | 0.04% | 0.05% | 0.05% | Q3 2023 | Q1 2024 | 3 |
EIGR | EIGER BIOPHARMACEUTICA... | 3 | 3 | 0.02% | 0.05% | 0.09% | Q4 2017 | Q2 2018 | 3 |
XOMETRY INC | 3 | 3 | 0.03% | 0.03% | 0.03% | Q2 2023 | Q4 2023 | 3 | |
INTU | INTUIT | 3 | 3 | 0.02% | 0.03% | 0.04% | Q4 2023 | Q2 2024 | 3 |
AMD | ADVANCED MICRO DEVICES... | 3 | 3 | 0.01% | 0.02% | 0.04% | Q3 2020 | Q1 2021 | 3 |
SAREPTA THERAPEUTICS INC | 3 | 3 | 0.02% | 0.02% | 0.03% | Q4 2019 | Q2 2020 | 3 | |
BIP | BROOKFIELD INFRAST PAR... | 2 | 1 | 0.00% | 0.01% | 0.02% | Q4 2015 | Q4 2016 | 3 |
ALGN | ALIGN TECHNOLOGY INC | 3 | 3 | 0.01% | 0.01% | 0.01% | Q2 2023 | Q4 2023 | 3 |
SYK | STRYKER CORP | 3 | 3 | 0.00% | 0.01% | 0.01% | Q3 2015 | Q1 2016 | 3 |
DLR | DIGITAL RLTY TR INC | 3 | 3 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q1 2016 | 3 |
SE | SPECTRA ENERGY CORP | 3 | 3 | 0.00% | 0.00% | 0.01% | Q3 2015 | Q1 2016 | 3 |
RMR | RMR GROUP INC | 3 | 3 | 0.00% | 0.00% | 0.00% | Q4 2015 | Q2 2016 | 3 |
SEND | SENDGRID INC | 2 | 2 | 2.66% | 3.04% | 3.43% | Q3 2018 | Q4 2018 | 2 |
ROC | ROCKWOOD HLDGS INC | 2 | 2 | 1.76% | 1.86% | 1.97% | Q1 2014 | Q2 2014 | 2 |
SERV | SERVICEMASTER GLOBAL H... | 2 | 2 | 1.10% | 1.24% | 1.38% | Q2 2019 | Q3 2019 | 2 |
SJM | SMUCKER J M CO | 2 | 2 | 0.70% | 0.93% | 1.15% | Q4 2013 | Q1 2014 | 2 |
3106PS | DELPHI AUTOMOTIVE PLC | 2 | 2 | 0.86% | 0.87% | 0.88% | Q2 2017 | Q3 2017 | 2 |
NOV | NATIONAL OILWELL VARCO... | 2 | 2 | 0.57% | 0.87% | 1.16% | Q4 2013 | Q1 2014 | 2 |
ECL | ECOLAB INC | 2 | 2 | 0.76% | 0.83% | 0.90% | Q3 2020 | Q4 2020 | 2 |
GITLAB INC | 2 | 2 | 0.64% | 0.74% | 0.84% | Q1 2024 | Q2 2024 | 2 | |
CPRT | COPART INC | 2 | 2 | 0.65% | 0.66% | 0.66% | Q1 2024 | Q2 2024 | 2 |
AKBA | AKEBIA THERAPEUTICS INC | 2 | 2 | 0.51% | 0.57% | 0.63% | Q2 2014 | Q3 2014 | 2 |
ESTC | ELASTIC N V | 2 | 2 | 0.41% | 0.49% | 0.58% | Q3 2019 | Q4 2019 | 2 |
CELC | CELCUITY INC | 2 | 2 | 0.43% | 0.45% | 0.47% | Q1 2024 | Q2 2024 | 2 |
IRM | IRON MTN INC DEL | 2 | 2 | 0.31% | 0.39% | 0.46% | Q1 2024 | Q2 2024 | 2 |
FDMT | 4D MOLECULAR THERAPEUT... | 2 | 2 | 0.32% | 0.35% | 0.39% | Q1 2024 | Q2 2024 | 2 |
MOBILEYE GLOBAL INC | 2 | 2 | 0.32% | 0.32% | 0.32% | Q1 2024 | Q2 2024 | 2 | |
BLU | BELLUS HEALTH INC NEW | 1 | 1 | 0.29% | 0.32% | 0.34% | Q2 2020 | Q1 2023 | 2 |
NTNX | NUTANIX INC | 2 | 2 | 0.02% | 0.31% | 0.60% | Q1 2024 | Q2 2024 | 2 |
PEG | PUBLIC SVC ENTERPRISE ... | 2 | 2 | 0.24% | 0.30% | 0.36% | Q1 2024 | Q2 2024 | 2 |
REMITLY GLOBAL INC | 2 | 2 | 0.26% | 0.30% | 0.34% | Q1 2024 | Q2 2024 | 2 | |
NTAP | NETAPP INC | 2 | 2 | 0.17% | 0.29% | 0.41% | Q1 2024 | Q2 2024 | 2 |
RTRX | RETROPHIN INC | 2 | 2 | 0.28% | 0.29% | 0.30% | Q2 2015 | Q3 2015 | 2 |
SHPG | SHIRE PLC | 2 | 2 | 0.23% | 0.25% | 0.28% | Q4 2013 | Q1 2014 | 2 |
RPHM | RENEO PHARMACEUTICALS INC | 2 | 2 | 0.19% | 0.24% | 0.28% | Q2 2023 | Q3 2023 | 2 |
ARQL | ARQULE INC | 2 | 2 | 0.13% | 0.24% | 0.35% | Q4 2018 | Q1 2019 | 2 |
RXDX | IGNYTA INC | 2 | 2 | 0.22% | 0.23% | 0.24% | Q2 2017 | Q3 2017 | 2 |
HSACU | HEALTH SCIENCES ACQUST... | 2 | 2 | 0.22% | 0.23% | 0.24% | Q2 2019 | Q3 2019 | 2 |
ESPR | ESPERION THERAPEUTICS ... | 2 | 2 | 0.17% | 0.22% | 0.27% | Q1 2015 | Q2 2015 | 2 |
AIT | APPLIED INDL TECHNOLOG... | 2 | 2 | 0.16% | 0.21% | 0.27% | Q1 2024 | Q2 2024 | 2 |
ALDR | ALDER BIOPHARMACEUTICA... | 2 | 2 | 0.11% | 0.20% | 0.29% | Q4 2016 | Q1 2017 | 2 |
ARWR | ARROWHEAD RESH CORP | 2 | 2 | 0.16% | 0.20% | 0.24% | Q2 2014 | Q3 2014 | 2 |
CONSTELLATION ENERGY CORP | 2 | 2 | 0.18% | 0.19% | 0.19% | Q1 2024 | Q2 2024 | 2 | |
FMI | FOUNDATION MEDICINE INC | 2 | 2 | 0.08% | 0.17% | 0.25% | Q4 2013 | Q1 2014 | 2 |
BLCM | BELLICUM PHARMACEUTICA... | 2 | 2 | 0.11% | 0.16% | 0.22% | Q4 2016 | Q1 2017 | 2 |
IMTX | IMMATICS N.V | 2 | 2 | 0.13% | 0.15% | 0.17% | Q3 2020 | Q4 2020 | 2 |
ATHX | ATHERSYS INC | 2 | 2 | 0.13% | 0.14% | 0.14% | Q4 2013 | Q1 2014 | 2 |
OPCH | OPTION CARE HEALTH INC | 2 | 2 | 0.13% | 0.13% | 0.14% | Q2 2022 | Q3 2022 | 2 |
CERS | CERUS CORP | 2 | 2 | 0.07% | 0.13% | 0.19% | Q4 2013 | Q1 2014 | 2 |
IOVA | IOVANCE BIOTHERAPEUTIC... | 2 | 2 | 0.12% | 0.13% | 0.15% | Q2 2018 | Q3 2018 | 2 |
MDAS | MEDASSETS INC | 2 | 2 | 0.10% | 0.13% | 0.16% | Q4 2013 | Q1 2014 | 2 |
KYMR | KYMERA THERAPEUTICS INC | 2 | 2 | 0.01% | 0.12% | 0.24% | Q1 2024 | Q2 2024 | 2 |
RLI | RLI CORP | 2 | 2 | 0.08% | 0.12% | 0.15% | Q1 2024 | Q2 2024 | 2 |
RMD | RESMED INC | 2 | 2 | 0.07% | 0.11% | 0.14% | Q4 2013 | Q1 2014 | 2 |
AVTE | AEROVATE THERAPEUTICS INC | 2 | 2 | 0.00% | 0.11% | 0.21% | Q4 2023 | Q1 2024 | 2 |
TIG | TIGENIX | 2 | 2 | 0.10% | 0.10% | 0.10% | Q4 2016 | Q1 2017 | 2 |
AEGR | AEGERION PHARMACEUTICA... | 2 | 2 | 0.09% | 0.09% | 0.09% | Q2 2014 | Q3 2014 | 2 |
AQN | ALGONQUIN PWR UTILS CORP | 2 | 2 | 0.04% | 0.08% | 0.12% | Q1 2020 | Q2 2020 | 2 |
OKE | ONEOK INC NEW | 2 | 2 | 0.08% | 0.08% | 0.09% | Q3 2019 | Q4 2019 | 2 |
CMPX | COMPASS THERAPEUTICS INC | 2 | 2 | 0.05% | 0.07% | 0.09% | Q3 2022 | Q4 2022 | 2 |
METAGENOMI INC | 2 | 2 | 0.04% | 0.07% | 0.10% | Q1 2024 | Q2 2024 | 2 | |
HTWR | HEARTWARE INTL INC | 2 | 2 | 0.04% | 0.07% | 0.09% | Q4 2013 | Q1 2014 | 2 |
BRKS | AZENTA INC | 2 | 2 | 0.04% | 0.06% | 0.08% | Q4 2021 | Q1 2022 | 2 |
CMTA | CLEMENTIA PHARMACEUTIC... | 2 | 2 | 0.06% | 0.06% | 0.06% | Q3 2017 | Q4 2017 | 2 |
RINGCENTRAL INC | 2 | 2 | 0.05% | 0.06% | 0.06% | Q1 2021 | Q2 2021 | 2 | |
AMWL | AMERICAN WELL CORP | 2 | 2 | 0.04% | 0.05% | 0.06% | Q3 2020 | Q4 2020 | 2 |
RXO INC | 2 | 2 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q1 2023 | 2 | |
NAYAX LTD | 2 | 2 | 0.03% | 0.03% | 0.04% | Q1 2024 | Q2 2024 | 2 | |
OTIS | OTIS WORLDWIDE CORP | 2 | 2 | 0.02% | 0.03% | 0.05% | Q1 2024 | Q2 2024 | 2 |
AMGN | AMGEN INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q1 2024 | Q2 2024 | 2 |
DPZ | DOMINOS PIZZA INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q3 2020 | Q4 2020 | 2 |
IMTXW | IMMATICS N.V | 2 | 2 | 0.02% | 0.02% | 0.03% | Q3 2020 | Q4 2020 | 2 |
UNP | UNION PAC CORP | 2 | 2 | 0.02% | 0.02% | 0.03% | Q1 2024 | Q2 2024 | 2 |
EQR | EQUITY RESIDENTIAL | 2 | 2 | 0.01% | 0.02% | 0.03% | Q2 2019 | Q3 2019 | 2 |
LLY | ELI LILLY & CO | 2 | 2 | 0.01% | 0.01% | 0.02% | Q1 2024 | Q2 2024 | 2 |
CCIPRA | CROWN CASTLE INTL CORP... | 2 | 2 | 0.01% | 0.01% | 0.01% | Q3 2019 | Q4 2019 | 2 |
SHOP | SHOPIFY INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q3 2023 | Q4 2023 | 2 |
TESLA MTRS INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q1 2016 | Q2 2016 | 2 | |
GOV | GOVERNMENT PPTYS INCOM... | 2 | 2 | 0.00% | 0.01% | 0.01% | Q4 2015 | Q1 2016 | 2 |
CDXS | CODEXIS INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q2 2015 | 2 |
ZFGN | ZAFGEN INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q1 2015 | 2 |
ASPEN TECHNOLOGY INC | 1 | 1 | 1.66% | 1.66% | 1.66% | Q4 2013 | Q4 2013 | 1 | |
SNDK | SANDISK CORP | 1 | 1 | 1.54% | 1.54% | 1.54% | Q1 2015 | Q1 2015 | 1 |
W | WAYFAIR INC | 1 | 1 | 0.97% | 0.97% | 0.97% | Q1 2020 | Q1 2020 | 1 |
SAGE | SAGE THERAPEUTICS INC | 1 | 1 | 0.86% | 0.86% | 0.86% | Q4 2017 | Q4 2017 | 1 |
DWSN | DAWSON GEOPHYSICAL CO | 1 | 1 | 0.68% | 0.68% | 0.68% | Q4 2013 | Q4 2013 | 1 |
NEXTRACKER INC | 1 | 1 | 0.63% | 0.63% | 0.63% | Q2 2024 | Q2 2024 | 1 | |
PS | PLURALSIGHT INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q2 2019 | Q2 2019 | 1 |
EDIT | EDITAS MEDICINE INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q4 2020 | Q4 2020 | 1 |
IMVTU | IMMUNOVANT INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q4 2019 | Q4 2019 | 1 |
NTLA | INTELLIA THERAPEUTICS INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q4 2020 | Q4 2020 | 1 |
GERN | GERON CORP | 1 | 1 | 0.46% | 0.46% | 0.46% | Q2 2024 | Q2 2024 | 1 |
WTRH | WAITR HLDGS INC | 1 | 1 | 0.43% | 0.43% | 0.43% | Q4 2018 | Q4 2018 | 1 |
AVB | AVALONBAY CMNTYS INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q2 2024 | Q2 2024 | 1 |
UTHR | UNITED THERAPEUTICS CO... | 1 | 1 | 0.37% | 0.37% | 0.37% | Q2 2024 | Q2 2024 | 1 |
LGVW | LONGVIEW ACQUISITION CORP | 1 | 1 | 0.34% | 0.34% | 0.34% | Q4 2020 | Q4 2020 | 1 |
HASHICORP INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2023 | Q2 2023 | 1 | |
FGEN | FIBROGEN INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q1 2023 | Q1 2023 | 1 |
JAMF | JAMF HLDG CORP | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2020 | Q3 2020 | 1 |
CLVS | CLOVIS ONCOLOGY INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q1 2014 | Q1 2014 | 1 |
ALKS | ALKERMES PLC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q2 2023 | Q2 2023 | 1 |
DYN | DYNE THERAPEUTICS INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q2 2024 | Q2 2024 | 1 |
ARYA | ARYA SCIENCES ACQUISIT... | 1 | 1 | 0.27% | 0.27% | 0.27% | Q2 2020 | Q2 2020 | 1 |
NCINO INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q1 2022 | Q1 2022 | 1 | |
RNA | AVIDITY BIOSCIENCES INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q2 2024 | Q2 2024 | 1 |
AESC | AES CORP | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2023 | Q1 2023 | 1 |
ALPN | ALPINE IMMUNE SCIENCES... | 1 | 1 | 0.25% | 0.25% | 0.25% | Q1 2024 | Q1 2024 | 1 |
IP | INTERNATIONAL PAPER CO | 1 | 1 | 0.25% | 0.25% | 0.25% | Q2 2024 | Q2 2024 | 1 |
ZIP | ZIPRECRUITER INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2023 | Q1 2023 | 1 |
RLAY | RELAY THERAPEUTICS INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q3 2020 | Q3 2020 | 1 |
HRTX | HERON THERAPEUTICS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2016 | Q4 2016 | 1 |
VSAR | VERSARTIS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2014 | Q2 2014 | 1 |
WPX | WPX ENERGY INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2014 | Q4 2014 | 1 |
ABCL | ABCELLERA BIOLOGICS INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q4 2020 | Q4 2020 | 1 |
FREQ | FREQUENCY THERAPEUTICS... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2023 | Q3 2023 | 1 |
NKTR | NEKTAR THERAPEUTICS | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2024 | Q2 2024 | 1 |
SGFY | SIGNIFY HEALTH INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2021 | Q1 2021 | 1 |
INBX | INHIBRX INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2023 | Q3 2023 | 1 |
DVN | DEVON ENERGY CORP NEW | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2022 | Q4 2022 | 1 |
GKOS | GLAUKOS CORP | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2024 | Q2 2024 | 1 |
CERC | CERECOR INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2019 | Q1 2019 | 1 |
BCAB | BIOATLA INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2022 | Q3 2022 | 1 |
TOURMALINE BIO INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2024 | Q1 2024 | 1 | |
KNTE | KINNATE BIOPHARMA INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2020 | Q4 2020 | 1 |
SVRA | SAVARA INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2019 | Q2 2019 | 1 |
ACCURAY INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2016 | Q1 2016 | 1 | |
MAAC | MONTES ARCHIMEDES ACQU... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2021 | Q2 2021 | 1 |
ONTX | ONCONOVA THERAPEUTICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2013 | Q4 2013 | 1 |
VVUS | VIVUS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2013 | Q4 2013 | 1 |
NEXTERA ENERGY INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2022 | Q4 2022 | 1 | |
ENPHASE ENERGY INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2022 | Q1 2022 | 1 | |
BXP | BOSTON PROPERTIES INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2019 | Q4 2019 | 1 |
NEXTERA ENERGY INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2023 | Q1 2023 | 1 | |
TNDM | TANDEM DIABETES CARE INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2018 | Q1 2018 | 1 |
TCF | TCF FINANCIAL CORPORAT... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2020 | Q2 2020 | 1 |
OLK | OLINK HLDG AB | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2021 | Q1 2021 | 1 |
IMVTW | IMMUNOVANT INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2020 | Q1 2020 | 1 |
ARYAW | ARYA SCIENCES ACQUISIT... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2020 | Q2 2020 | 1 |
MNLO | MENLO THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2018 | Q1 2018 | 1 |
DBTX | DECIBEL THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2021 | Q1 2021 | 1 |
HD | HOME DEPOT INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2024 | Q2 2024 | 1 |
RPM | RPM INTL INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2021 | Q3 2021 | 1 |
PXD | PIONEER NAT RES CO | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2023 | Q3 2023 | 1 |
INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2019 | Q4 2019 | 1 | |
FATE | FATE THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2020 | Q4 2020 | 1 |
RSG | REPUBLIC SVCS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2024 | Q2 2024 | 1 |
FNB | FNB CORP PA | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2019 | Q4 2019 | 1 |
PATH | UIPATH INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2021 | Q3 2021 | 1 |
NERDWALLET INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q2 2023 | 1 | |
INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2019 | Q4 2019 | 1 | |
MIRUM PHARMACEUTICALS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2024 | Q2 2024 | 1 | |
INFO | IHS MARKIT LTD | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2019 | Q4 2019 | 1 |
RAPPORT THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2024 | Q2 2024 | 1 | |
ESS | ESSEX PPTY TR INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2019 | Q3 2019 | 1 |
MU | MICRON TECHNOLOGY INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2024 | Q2 2024 | 1 |
TTD | THE TRADE DESK INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
SIVB | SVB FINL GROUP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2019 | Q4 2019 | 1 |
AYX | ALTERYX INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2021 | Q2 2021 | 1 |
LMND | LEMONADE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
BRBR | BELLRING BRANDS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2020 | Q2 2020 | 1 |
PLANET LABS PBC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2021 | Q4 2021 | 1 | |
ONTF | ON24 INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2021 | Q1 2021 | 1 |
NEWR | NEW RELIC INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
GNMA | ISHARES TR | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2015 | Q3 2015 | 1 |
AMWL | AMERICAN WELL CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
CCOI | COGENT COMMUNICATIONS ... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2020 | Q1 2020 | 1 |
HERCULES CAPITAL INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2019 | Q1 2019 | 1 | |
APPN | APPIAN CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
LMND | LEMONADE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2021 | Q2 2021 | 1 |
WDC | WESTERN DIGITAL CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2019 | Q1 2019 | 1 |
OSH | OAK STR HEALTH INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2020 | Q3 2020 | 1 |
ITC | ITC HLDGS CORP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2015 | Q4 2015 | 1 |
PATTERN ENERGY GROUP INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2019 | Q1 2019 | 1 | |
AGM | FEDERAL AGRIC MTG CORP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q3 2015 | 1 |
DLO | DLOCAL LTD | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q1 2023 | 1 |
HCN | HEALTH CARE REIT INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q3 2015 | 1 |
Download |
The securities at the top of the list , including LOWES COS INC, PALO ALTO NETWORKS INC, and ASML HOLDINGS NV, are the highest-conviction holdings of Eventide Asset Management.
The conviction is calculated by counting the number of quarters a security has been reported by Eventide Asset Management. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Eventide Asset Management owns currently or has owned in the past.